Tamiflu (oseltamivir phosphate) Capsules and Oral Suspension
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
WARNINGS AND PRECAUTIONS
Serious Skin/Hypersensitivity Reactions
(Addition of sentence to section)The use of...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts